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Several biological and epidemiological studies support a relationship between smoking and
Helicobacter pylori (H. pylori) to increase the risk of pathology. However, there have been
few studies on the potential synergistic association between specific cagA and vacA viru-
lence factors and smoking in patients infected by Helicobacter pylori. We studied the rela-
tionship between smoking and cagA, vacA i1 virulence factors and bacterial load in H. pylori
infected patients.
Methods
Biopsies of the gastric corpus and antrum from 155 consecutive patients in whom there was
clinical suspicion of infection by H. pylori were processed. In 106 patients H. pylori infection
was detected. Molecular methods were used to quantify the number of microorganisms and
presence of cagA and vacA i1 genes. A standardized questionnaire was used to obtain pa-
tients’ clinical data and lifestyle variables, including tobacco and alcohol consumption. Ad-
justed Odds Ratios (ORadjusted) were estimated by unconditional logistic regression.
Results
cagA was significantly associated with active-smoking at endoscope: ORadjusted 4.52. Evi-
dence of association was found for vacA i1 (ORadjusted 3.15). Bacterial load was higher in
active-smokers, although these differences did not yield statistical significance (median of
262.2 versus 79.4 copies of H. pylori per cell).
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Conclusions
The association between smoking and a higher risk of being infected by a virulent bacterial
population and with higher bacterial load, support a complex interaction between H. pylori
infection and environmental factors.
Introduction
Interaction between Helicobacter pylori (H. pylori) and gastric mucosa is a complex phenome-
non and as yet little understood. Though in most cases this microorganism does not cause any
symptomatic pathology, in some cases it causes serious lesions in the mucosa, being the main
risk factor for gastric cancer. This different patterns of evolution may be related to the host’s
characteristics (genetic, immunological), environmental exposures (socio-sanitary and life-
style factors), and also to certain characteristics of the microorganism [1].
Many virulence genes have been described in H. pylori, and attempts have been made to as-
sociate them with different diseases. One of the most widely studied factors is the virulence
cagA gene. This gene encodes the CagA protein, which can be directly injected by the bacteri-
um into colonized epithelium via a type IV secretion system, leading to cellular morphological,
anti-apoptotic and proinflammatory effects responsible in the long-term (years or decades) for
ulcer and cancer [2].
Other virulence gene described in H. pylori is vacA, which encodes VacA, a vacuolating cy-
totoxin initially identified for its ability to induce vacuolation in epithelial cells [1,3–5]. Though
all strains contain vacA, this gene contains three distinct segments that exhibit variation start-
ing within the amino terminus. These areas of variation are broadly defined as the signal (s), in-
termediate (i), and middle (m) regions, and two or more primary variants have been described
for each region: s1 and s2 for the signal region, i1, i2, and i3 for the intermediate region, and
m1 andm2 for the middle region [1,5–8]. Several studies have linked strains carrying the
s1-m1 allele of the toxin to more-severe disease outcomes, since these strains show the stron-
gest vacuolating activity to the broadest range of cells [9]. The i region is positioned between
the s andm regions and is the most recent region to be described. The i1 variants of vacA have
been shown to have stronger vacuolating activity than toxins containing the i2 regions and re-
cently, the i region has been suggested to be a better predictor of disease severity than either the
s orm region, though the i region appears to covary with the s andm regions. This means that
the more toxic i1 region is often associated with s1-m1 [7].
In addition, some studies have also described an association between the presence of a great-
er number of microorganisms and more serious gastric lesions with independence of these vir-
ulence factors [10,11].
Regarding the host’s characteristics, several biological [12,13] and epidemiological studies
support a relationship between smoking and H. pylori to increase the risk of pathology [14–
17].
However, there have been few studies on the potential synergistic association between spe-
cific cagA and vacA virulence factors and tobacco use (chewing or smoking) [18,19,20] and to
the best of our knowledge, there are not published studies on the relationship between tobacco
use and H. pylori bacterial load.
Our aim was to study the relationship between smoking and cagA, vacA i1 virulence factors
and bacterial load in H. pylori infected patients.
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Material and Methods
Ethics Statement
All subjects were informed of the study objectives and gave their informed consent prior to
their inclusion in the study. The research protocol was approved by the local ethics and re-
search committees of the participating hospital: "Comité de bioética asistencial (CBA) Dpto
Salud 20-H. General" and "Comité ético de investigación clínica (CEIC) del Hospital General
Universitario de Elche". Patient records/information was anonymized and de-identified prior
to analysis."
Design and participants
Details of this study have been published elsewhere [11,21,22]. Biopsies of the gastric corpus
and antrum from 155 consecutive patients in whom there was clinical suspicion of infection by
H. pylori were processed: duodenal ulcer (n = 67), duodenitis (n = 19), gastric ulcer (n = 36),
gastritis (n = 5), dyspepsia (n = 11), family history of gastric cancer (n = 3), and eradication
failure (n = 14).
Prospective study including biopsies of the gastric corpus and antrum obtained from the
first 155 symptomatic patients who consecutively attended the Endoscopy Unit of Elche Uni-
versity General Hospital for an upper digestive tract endoscopy between January 2009 and
June 2010, in whom investigation ofH. pylori was indicated
Data sources and variables
Measures. A standardized questionnaire was used to obtain patients’ clinical data and life-
style variables, including tobacco and alcohol consumption. Smoking habit was classified at the
time of endoscope as ‘active smokers’ versus ‘non active smokers’. An ‘active smoker’ was de-
fined as an smoker at the time the endoscope was performed or up to a week previously, irre-
spective of the number of cigarettes smoked per day and for how many years. In a second step,
a never smoker was defined as someone having smoked fewer than 100 cigarettes ever or less
than one cigarette per day for one year. A former smoker was defined as someone having
stopped smoking 1 or more years before the endoscope.
S1 Table shows the age, gender, clinical characteristics and lifestyles of the 155 patients in
relation to smoking status at endoscope.
H. pylori infection was detected in 106 patients according to a validated real-time polymer-
ase chain reaction (PCR) [21] that also allows quantifying the number of microorganisms per
cell. In 96 and 73 out of these 106 patients, the remains of biopsies allowed us to determine
cagA, and vacA i1 genes respectively.
cagA determination and vacA i1 region sequencing. Detection of the cagA gene was
done using a real-time PCR system designed in our laboratory [11,21]. After that, we also de-
signed a nested PCR for the amplification of the intermediate region (i) the gene vacA, permit-
ting the classification of the gene fragment at i1, i2 and i3 through three clusters (A, B and C)
[5]. Primers used in the study of the virulence factors of H. Pylori are shown in S2 Table.
Quantification of the number of microorganisms. The quantification of the microorganisms
was carried out by amplifying a fragment of the urease gene; the results were expressed as the
quotient of the number of microorganisms and the number of human cells in each gastric sam-
ple [21].
Smoking and High VirulenceH. pylori
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Statistical analyses
A non-parametric test (U MannWhitney for independent samples) was used to compare the
number of microorganisms in the biopsy and smoking status. In order to estimate the associa-
tion between cagA and vacA i1 virulence factors, and bacterial load and tobacco smoking, ad-
justed odds ratios (ORadjusted) and 95% confidence intervals (95%CI) were calculated using
unconditional logistic regression. All regression models included as covariates sex, age (< = 50
years,>50 years), average of pure ethanol (g/day) (never, moderate, high), consumption of PPI
in the days prior to endoscopy (yes/no), consumption of NSAID (yes/no), and clinical presen-
tation of UDTH (yes/no) entered as indicator variables.
Tests for trend in the ORs across exposure strata were calculated for tobacco smoking ordi-
nal categorised (never, former, current smoker) by using logistic models that included categori-
cal terms as continuous variables in a model with all the potential confounders. For trend-tests,
we used the likelihood ratio test statistic with one degree of freedom.
The level of statistical significance was set at 0.05 and all tests were two-tailed. All analyses
were performed with SPSS v.21.0.
Results
Table 1 presents the association between cagA and tobacco consumption. There was a statisti-
cally significant association between cagA positive status and active smoking at endoscope
(ORadjusted 4.52; 95%CI 1.28–15.98). Table 2 shows the associations between vacA i1 region sta-
tus and active smoking at endoscope. vacA i1 positivity is associated with smoking, though this
association does not attain statistical significance (crude OR 2.69; 95% CI 0.92–7.92).
Finally, bacterial load was very asymmetric and presented a high variability. The number of
copies of H. pylori per cell in antrum according to real-time PCR was higher in active-smokers:
Median = 262.2 [Interquartile Range = 2079.0] than in no active-smokers: Median = 79.4
[Interquartile Range = 890.8], although these differences were not statistically significant
(p = 0.35). Positive associations without yielding statistical significance were found between ac-
tive smoking and the number of microorganisms when the bacterial load was divided into
above and below median: ORadjusted 2.26 (95% CI 0.76–6.75) (see Table 3).
For both cagA and vacA i1 virulence factors and bacterial load, a dose response pattern was
obtained when non active smokers were divided into never and former smokers (current smok-
ers were at higher risk than former smokers).
Table 1. Association between cagA status and tobacco smoking.
N cagA neg N cagA pos OR 95% CI ORadjusteda 95% CI
Smoking Status at endoscope
Non active smokers 34 31 1.00 1.00
Active smokers 8 23 3.15 1.23 8.07 4.52 1.28 15.98
Smoking Status
Never 22 23 1.00 1.00
Former smoker 12 8 0.64 0.22 1.86 0.36 0.09 1.53
Current smoker 8 23 2.75 1.02 7.43 3.24 0.84 12.47
p-value for linear trend 0.067 0.123
aAdjusted for sex, age (< = 50 years, >50 years), average of pure ethanol (g/day) (Never, moderate, high), consumption of proton pump inhibitors in the
days prior to endoscopy (Yes/No), consumption of non-steroid anti-inflammatory drugs (Yes/No), and clinical presentation of upper digestive tract
haemorrhage (Yes/No).
doi:10.1371/journal.pone.0120444.t001
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Discussion
Overall, in our study, when restricting toH. pylori infected patients, active smokers were at a
higher risk of colonization by cagA positive virulent strains at the time of endoscope. Although
results did not yield statistical significance, active smoking was also associated to vacA i1 viru-
lent strains and higher bacterial loads.
First contact withH. pylori is documented by a transmission of the bacteria within families,
predominantly in the early childhood [23,24]. However, it has been found that the genome of
H. pylori changes continuously during chronic colonization of an individual host with mixed
strains by importing small pieces of foreign DNA from other strains during persistent or tran-
sient mixed infections [25–27].
The co-colonization of H. pylori could permit inter-strain DNA transfer, which could speed
up the emergence of new strains/subpopulations that are better adapted or more virulent in a
given human host than the initial infecting strains [25, 28–30].
The higher bile salt reflux and gastric bile salt and the lower concentrations of vitamin C in
gastric juices [12,13] in smokers in comparison with non-smokers support a biological
Table 2. Association between vacA i1 intermediate region status and tobacco smoking.
N vacA Region_i1neg N vacA Region_i1 pos OR 95% CI ORadjusteda 95% CI
Smoking status at endoscope
Non active smokers 21 26 1.00 1.00
Active smokers 6 20 2.69 0.92 7.92 3.15 0.74 13.39
Smoking status
Never 12 21 1.00 1.00
Former smoker 9 5 0.32 0.09 1.17 0.38 0.07 2.13
Current smoker 6 20 1.91 0.60 6.05 2.20 0.46 10.58
p-value for linear trend 0.356 0.351
aAdjusted for sex, age (< = 50 years, >50 years), average of pure ethanol (g/day) (Never, moderate, high), consumption of proton pump inhibitors in the
days prior to endoscopy (Yes/No), consumption of non-steroid anti-inflammatory drugs (Yes/No), and clinical presentation of upper digestive tract
haemorrhage (Yes/No).
doi:10.1371/journal.pone.0120444.t002
Table 3. Association between bacterial load and tobacco smoking.
H. pylori bacterial load
 Median (N) > Median (N) OR 95% CI ORadjusteda 95% CI
Smoking Status at endoscope
Non active smokers 39 33 1.00 1.00
Active smokers* 14 20 1.69 0.74 3.85 2.26 0.76 6.75
Smoking status
Never 28 21 1.00 1.00
Formersmoker 11 12 1.45 0.54 3.93 1.29 0.34 4.90
Current smoker 14 20 1.90 0.78 4.62 2.47 0.76 8.06
p-value for linear trend 0.150 0.137
aAdjusted for sex, age (< = 50 years, >50 years), average of pure ethanol (g/day) (Never, moderate, high), consumption of proton pump inhibitors in the
days prior to endoscopy (Yes/No), consumption of non-steroid anti-inflammatory drugs (Yes/No), and clinical presentation of upper digestive tract
haemorrhage (Yes/No).
doi:10.1371/journal.pone.0120444.t003
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plausibility on the relationship between smoking and a higher prevalence of new more virulent
strains with higher bacterial loads.
A growing number of studies have begun to suggest that vacA and cagA interact in such a
way as to affect disease severity [31–34]. In a previous work we found that the cagA gene was
associated with high bacterial load with a clear, statistically significant dose-response relation-
ship between load and presence of cagA. These data suggest that both parameters combine to
produce clinically significant lesions, as compared with strains of low virulence that multiply
very little in the gastric mucosa and so do not cause significant damage [11].
Our present data suggest that smoking could be a synergistic factor, interacting with both
bacterial load andH. pylori virulence factors. Published studies would support an interaction
between high virulence factors and smoking to increase the risk of intestinal metaplasia [14,18]
and gastric cancer [15–17,19]. Recently, an association between cagA and other types of tobac-
co use such as tobacco-chewing has been also documented [20].
Since a synergistic effect seems plausible, the presence of high virulence strains of H. pylori
should be included as a confusion variable and as a term of interaction in the associations tradi-
tionally established between smoking and gastric cancer [35,36].
If this hypothesised synergistic effect is firmly established, smoking cessation would be asso-
ciated with a lower risk of high virulence strains infection, so the combined effect of smoking
andH. Pylori trends on past and future gastric cancer incidence, could be higher than estimat-
ed by microsimulation models [37].
Up to our knowledge, this is the first study on the specific relationship between smoking
and bacterial load. Since our results did not yield statistical significance, because of the asym-
metry and high variability of bacterial load, further prospective studies with higher sample size
and statistical power are necessaries to corroborate these findings.
Number of CagA Glu-Pro-Ile-Tyr-Ala (EPIYA)-C segments (with multiple repeats increas-
ing the virulence) may explain, to some extent, geographic differences in the incidence of gas-
tric cancer in Western countries. It would be interesting to go in depth in relation to the
association between smoking and these specific patterns of cagA gene repeat sequences. Further
studies are also required to continue studying the relationship between tobacco and vacA al-
leles, as well as other more recently discovered virulence factors [38,39].
In conclusion, the associations between smoking and a higher prevalence of virulent bacteri-
al population with higher bacterial loads, support a complex interaction between the microor-
ganism, gastric mucosa and environmental factors such as tobacco smoking, in which
synergistic effects could increase gastric pathology.
Supporting Information
S1 Table. Baseline characteristics of patients as a function of Smoking Status at endoscope.
aSD denotes Standard Deviation bAlcoholism (high alcohol consumption) was defined as a
consumption of more than 80g/day in men and 60 g/day in women cA Coffee/Tea Drinker at
the endoscope was defined as someone having consumed at least two cups at week for at least
one year. dComorbidity was defined as someone having high blood pressure, diabetes, cardiop-
athy, chronic obstructive pulmonary disease, or kidney failure.
(PDF)
S2 Table. Primers used in the study of the virulence factors ofH. pylori.
(PDF)
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